Investing.com - Mainz Biomed BV reported on Wednesday second quarter earnings that matched analysts' forecasts and revenue that was inline with expectations.
Mainz Biomed BV announced earnings per share of $-0.46 on revenue of $150K. Analysts polled by Investing.com EPS of $-0.46 on revenue of $150K.
Mainz Biomed BV 's are down 13% and is trading at $8.69 , still down 71.03% from its 52 week high of $30.00 set on Tuesday, January 18, 2022.
Mainz Biomed BV follows other major Healthcare sector earnings this month
Mainz Biomed BV's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of $1.13 on revenue of $7.37B, EPS of $1.12 on revenue of $7.22B.
Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of $1.34 on revenue of $1.72B, for EPS of $1.2 on revenue of $1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar